Stan Berenshteyn
Stock Analyst at Wells Fargo
(2.06)
# 3,018
Out of 4,981 analysts
67
Total ratings
47.37%
Success rate
-7.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $326 → $341 | $276.43 | +23.36% | 8 | Aug 28, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $6 | $3.13 | +91.69% | 6 | Aug 11, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $71.03 | -8.49% | 12 | Aug 8, 2025 | |
| AMWL American Well | Maintains: Overweight | $15 → $12 | $6.64 | +80.72% | 4 | Aug 7, 2025 | |
| OMCL Omnicell | Maintains: Overweight | $37 → $40 | $31.83 | +25.67% | 17 | Jul 21, 2025 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $7.68 | +4.17% | 3 | May 8, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $4.19 | +67.06% | 8 | Apr 29, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $125 | $92.49 | +35.15% | 9 | Feb 26, 2025 |
Veeva Systems
Aug 28, 2025
Maintains: Overweight
Price Target: $326 → $341
Current: $276.43
Upside: +23.36%
Health Catalyst
Aug 11, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $3.13
Upside: +91.69%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $71.03
Upside: -8.49%
American Well
Aug 7, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $6.64
Upside: +80.72%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $31.83
Upside: +25.67%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $7.68
Upside: +4.17%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $4.19
Upside: +67.06%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $92.49
Upside: +35.15%